Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1–AKT–p53 Interactions.

Published in:

Cancers, 2021, v. 13, n. 9, p. 2195, doi. 10.3390/cancers13092195

By:

• Lynch, Katherine N.;
• Liu, Joyce F.;
• Kesten, Nikolas;
• Chow, Kin-Hoe;
• Shetty, Aniket;
• He, Ruiyang;
• Afreen, Mosammat Faria;
• Yuan, Liping;
• Matulonis, Ursula A.;
• Growdon, Whitfield B.;
• Muto, Michael G.;
• Horowitz, Neil S.;
• Feltmate, Colleen M.;
• Worley Jr., Michael J.;
• Berkowitz, Ross S.;
• Crum, Christopher P.;
• Rueda, Bo R.;
• Hill, Sarah J.;
• Horikawa, Izumi

Publication type:

Article